PHARMATECA » Search Articles by Keyword
Found: 8 articles
Article |
Edition |
M.E. Abramov, T.E. Tikhomirova, O.E. Ryabishina, A.A. Rumyantsev, A.S. Tyulandina
Gastrointestinal stromal tumors: prospects for drug therapy of metastatic or inoperable forms
|
№6-7 / 2023
|
A.S. Odintsova, V.A. Gorbunova, N.F. Orel, A.A. Markovich, A.E. Kuzminov, S.A. Polozkova, G.S. Emelyanova, A.A. Kuznetsova
THE USE OF SUNITINIB IN PANCREATIC NEUROENDOCRINE TUMORS: EXPERIENCE OF THE DEPARTMENT OF CHEMOTHERAPY FSBI RORC N.A. N.N. BLOKHIN OF RMH
|
№17 / 2016
|
M.S. Sayapina, D.A. Nosov
MODERN APPROACHES TO TREATMENT OF RENAL CELL CARCINOMA ACCORDING TO THE MATERIALS OF THE VII INTERNATIONAL CONFERENCE OF RENAL CANCER EXPERTS (CORE, 2016)
|
№8 / 2016
|
Yu Alyaev, E. V. Shpot
Renal Cell Carcinoma. Past, Present And Future
|
№18-19 / 2010
|
M.I. Volkova
Conference Of Renal Cancer Experts: A Review Of Materials
|
№17 / 2010
|
L.G.Zhukova, K.A. Vorontsova
Sunitinib In The Treatment Of Patients With Progression Of Gastrointestinal Stromal Tumors After Use Of Imatinib (gleevec)
|
№17 / 2010
|
Timofeev I.V.
First line therapy of metastaric renal carcinoma
|
№6 / 2010
|
S.L. Gutorov, E.I. Borisova, M.R. Lichinicer
Sunitinib (sutent) In The First Line Of Metastatic Renal Cell Carcinoma
|
№18 / 2009
|
{"loading":"Loading...","close":"Close","yes":"Yes","no":"No","proceed":"Proceed","conf_del":"Do you really want to delete","cancel":"Cancel"}